CORONAVIRUS

AstraZeneca's same vaccine is manufactured and marketed in India as Covishield.

Updated : May 2, 2024

'Covaxin was developed with safety focus’: Bharat Biotech on Covishield blood clot row

AstraZeneca has said that in “very rare cases”, its Covid-19 vaccine can cause low platelet count and a blood clot-related side effect – Thrombosis Thrombocytopenia Syndrome (TTS)

Saurabh Bharadwaj said that many people speculate a connection between the coronavirus vaccine and deaths of young people due to collapsing.

Updated : May 1, 2024

'India continued with Covishield even after adverse reports': AAP's Saurabh Bharadwaj targets Centre as AstraZeneca admits side effect

The AAP leader's remarks came a day after British pharma giant AstraZeneca admitted in a UK court that its anti-COVID vaccine sold globally as Covishield and Vaxzevria may cause Thrombocytopenia Syndrome (TTS) in "very rare cases."

In India, the Vaxzevria vaccine of AstraZeneca was produced by Adar Poonawalla-led Serum Institute of India (SII) and marketed as Covishield.

Updated : May 1, 2024

'Sympathy goes out to anyone who lost loved ones,' says AstraZeneca on Covishield row

The admission came a day after the pharma giant admitted in a UK court that its COVID-19 vaccine sold globally as Covishield and Vaxzevria may cause Thrombocytopenia Syndrome (TTS) in "very rare cases".

In India, Covishield is manufactured by the Serum Institute of India (SII) under a licensing agreement with AstraZeneca.

Updated : Apr 30, 2024

AstraZeneca's admission of Covishield risk may spark legal battles in India

The vaccine producer stated in court documents that the inoculation could occasionally induce Thrombosis with Thrombocytopenia Syndrome (TTS), a disorder resulting in blood clots and a reduced platelet count, as reported in The Telegraph.

Persistent Covid-19 Cases Rampant, Raising Concerns on Long-Term Impacts & New Variants, Study Reveals

Updated : Mar 7, 2024

Persistent Covid infections may be more common than expected: Report

The researchers estimate that between one in a thousand to one in 200 of all infections may become persistent, and last for at least 60 days

Man Receives 217 COVID-19 Vaccines, Surprisingly Keeps Fully Functional Immune System: New Findings Revealed

Updated : Mar 6, 2024

No impact on immune system of man who received over 200 COVID-19 vaccinations: Lancet study

A German man who claimed to have received 217 COVID-19 vaccinations has been examined by researchers and found to have a fully functional immune system.